• Capricor Therapeutics (NASDAQ:CAPR) Raised to “Buy” at Zacks Investment Research

    … in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California. “.

    Read More
  • 0 0